BSEM · BioStem Technologies, Inc. · Insider Trading

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units will vest in equal quarterly installments over three years from the grant date (September 15, 2024).

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest quarterly over three years from the grant date (September 15, 2024).

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in equal quarterly installments over four years from the grant date (December 9, 2024).

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vested on August 27, 2026.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vested on August 27, 2026.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in two installments. The first installment vested on May 27, 2026, and the remaining installment vested on August 27, 2026.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vested quarterly over the year following the grant date (August 27, 2025).

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vested on August 27, 2026.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest according to the following schedule: 33% vested on August 11, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Due to an administrative error, the vesting of the restricted stock units was not timely reported on a Form 4 within two business days of the applicable transaction date.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest according to the following schedule: 33% vested on May 9, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Due to an administrative error, the vesting of the restricted stock units was not timely reported on a Form 4 within two business day of the applicable transaction date.